logo
  • Projects
  • Opportunities
  • Organisations
Log inSign up
logo
  • Projects
  • Opportunities
  • Organisations
logoSubscribe to our Newsletter
The Innovation Exchange supports the Sustainable Development Goals
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
  • Acceptable Use Policy
A continuous in vitro culture system for Cryptosporidium

Published by

Global-Innovation

Global-Innovation Exchange

Project start date: 5/19/2018

A continuous in vitro culture system for Cryptosporidium

L. David Sibley and colleagues at Washington University School of Medicine in the U.S. will generate epithelial cells derived from isolated intestinal stem cells for the continuous in vitro culture of the parasite Cryptosporidium, which causes severe diarrheal disease in humans and animals, and is refractory to many anti-parasitic drugs. Currently, Cryptosporidium can only be grown in infected calves and short term in vitro cultures, precluding high-throughput chemical screens for new drugs.

Development & Testing

1 - 6 months

Last update: October 05, 2023

OverviewContributors

Challenge

Cryptosporidium causes severe diarrheal disease in humans and animals and is refractory to many anti-parasitic drugs. Currently, Cryptosporidium can only be grown in infected calves and short-term in vitro cultures, precluding high-throughput chemical screens for new drugs.

Description

Washington University School of Medicine will generate epithelial cells derived from isolated intestinal stem cells for the continuous in vitro culture of Cryptosporidium.

SDGs

Good Health and Well-being

Outcomes

Expected outcomes include the development of a continuous in vitro culture system for Cryptosporidium, facilitating high-throughput chemical screens for new drugs.